Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn C Knollmann

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Heart Rhythm|August 3, 2010
Power and pitfalls of using transgenic mice to optimize therapy for CPVT: a need for prospective placebo-controlled clinical trials in genetic arrhythmia disordersBjörn C Knollmann
The Journal of Physiology|July 16, 2020
Cardiac regulatory mechanisms: from cardiac mechanisms to novel therapeutic approachesBjörn C Knollmann
The Journal of Physiology|May 20, 2009
New roles of calsequestrin and triadin in cardiac muscleBjörn C Knollmann
Circulation Research|April 10, 2013
Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?Björn C Knollmann
Nature Medicine|August 6, 2011
Carvedilol tweaks calcium release to ease arrhythmiasBjörn C Knollmann
Nature Methods|October 30, 2010
Pacing lightly: optogenetics gets to the heartBjörn C Knollmann
The Journal of Physiology|June 18, 2017
Cardiac regulatory mechanisms: new concepts and challengesBjörn C Knollmann
Journal of Cardiovascular Electrophysiology|July 1, 2009
Cardiac calsequestrin: the new kid on the block in arrhythmiasNagesh Chopra, Björn C Knollmann
Current Opinion in Cardiology|March 25, 2011
Genetics of sudden cardiac death syndromesNagesh Chopra, Björn C Knollmann
American Journal of Physiology. Heart and Circulatory Physiology|December 27, 2011
Calsequestrin 2 and arrhythmiasMichela Faggioni, Björn C Knollmann
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Heart Rhythm|August 3, 2010
Power and pitfalls of using transgenic mice to optimize therapy for CPVT: a need for prospective placebo-controlled clinical trials in genetic arrhythmia disordersBjörn C Knollmann
The Journal of Physiology|July 16, 2020
Cardiac regulatory mechanisms: from cardiac mechanisms to novel therapeutic approachesBjörn C Knollmann
The Journal of Physiology|May 20, 2009
New roles of calsequestrin and triadin in cardiac muscleBjörn C Knollmann
Circulation Research|April 10, 2013
Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?Björn C Knollmann
Nature Medicine|August 6, 2011
Carvedilol tweaks calcium release to ease arrhythmiasBjörn C Knollmann
Nature Methods|October 30, 2010
Pacing lightly: optogenetics gets to the heartBjörn C Knollmann
The Journal of Physiology|June 18, 2017
Cardiac regulatory mechanisms: new concepts and challengesBjörn C Knollmann
Journal of Cardiovascular Electrophysiology|July 1, 2009
Cardiac calsequestrin: the new kid on the block in arrhythmiasNagesh Chopra, Björn C Knollmann
Current Opinion in Cardiology|March 25, 2011
Genetics of sudden cardiac death syndromesNagesh Chopra, Björn C Knollmann
American Journal of Physiology. Heart and Circulatory Physiology|December 27, 2011
Calsequestrin 2 and arrhythmiasMichela Faggioni, Björn C Knollmann
Pageof 11